J&J applies for COVID-19 shot authorization in Japan

Monday, 24. May 2021 07:00

Johnson & Johnson announced on Monday that it filed for approval of its coronavirus vaccine in Japan. The pharmaceutical giant stated it could start delivering the one-dose shots to the country in early 2022. Japan has so far authorized the use of vaccines made by Pfizer/BioNTech, AstraZeneca and Moderna.

The Johnson & Johnson shot faced controversy as some patients developed blood clots after receiving it. A number of countries issued warnings limiting its use, while the United States paused it in April until the Centers for Disease Control and Prevention (CDC) decided it was safe to resume using it.

Related Links: Johnson & Johnson
Breaking the News / DJ